You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tepotinib

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Houston (Amivantamab, Tepotinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Advanced Cancer, Non Small Cell Lung Cancer Trial (Tepotinib, Pembrolizumab)

Not yet recruiting
  • Advanced Cancer
  • Non Small Cell Lung Cancer
  • (no location specified)
Mar 28, 2023

NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Oct 27, 2023

Healthy Trial in Neu-Ulm (Tepotinib, Omeprazole)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Aug 22, 2022

Hepatic Impairment Trial in Miami, Orlando (Tepotinib)

Completed
  • Hepatic Impairment
  • Tepotinib
  • Miami, Florida
  • +1 more
Aug 22, 2022

Brain Tumor Trial in Houston (tepotinib, tepotinib plus osimertinib)

Not yet recruiting
  • Brain Tumor
  • tepotinib
  • tepotinib plus osimertinib
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Advanced NSCLC With MET Mutations Trial in United States (Tepotinib)

Recruiting
  • Advanced Non-Small Cell Lung Cancer With MET Mutations
  • Tepotinib
  • Aurora, Colorado
  • +3 more
Jun 27, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Carcinoma, Hepatocellular Trial in Darmstadt (Tepotinib)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Tepotinib
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center located in
Aug 22, 2022

NSCLC Trial in Worldwide (Tepotinib, Gefitinib, Pemetrexed)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Tepotinib
  • +4 more
  • Beijing, China
  • +43 more
Oct 13, 2022

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Tepotinib 300 mg
  • +4 more
  • Beijing, Beijing, China
  • +42 more
Aug 22, 2022

Colorectal Tumors Trial in Worldwide (Tepotinib, Cetuximab)

Active, not recruiting
  • Colorectal Neoplasms
  • Tepotinib
  • Cetuximab
  • Phoenix, Arizona
  • +66 more
Nov 19, 2021

Solid Tumor, MET Exon 14 Skipping Mutation, MET Amplification Trial in Korea, Republic of (Tepotinib)

Recruiting
  • Solid Tumor
  • +2 more
  • Tepotinib
  • Hwasun, Chonnam, Korea, Republic of
  • +21 more
Nov 30, 2020

NSCLC Trial in Worldwide (Tepotinib, Osimertinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Yuma, Arizona
  • +178 more
Dec 19, 2022

Advanced (Stage IIIB/IV) NSCLC (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification Trial in Worldwide

Active, not recruiting
  • Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification
  • Tepotinib
  • Duarte, California
  • +140 more
Jun 7, 2022

Healthy Trial in Neu-Ulm (Midazolam, Tepotinib)

Completed
  • Healthy
  • Neu-Ulm, Germany
    Nuvisan GmbH
Jun 21, 2019

Healthy Trial in Neu-Ulm (Dabigatran Etexilate, Tepotinib)

Completed
  • Healthy
  • Dabigatran Etexilate
  • Tepotinib
  • Neu-Ulm, Germany
    Nuvisan GmbH
Jun 4, 2019